The completion of the buyout is expected to help Catalent significantly strengthen its foothold in the global Cell and Gene Therapy business. Notably ...
https://www.google.com/url?rct=j&sa=t&url=https://finance.yahoo.com/news/catalent-ctlt-enhance-portfolio-via-152403454.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFq2V8AfZk02D8-KvgJ32lMdZlK8g
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.